Tag: Food and Drug Administration
-
Surprise: Actos Bladder Cancer Risk Is Up to 83 Percent
0 Likes Thank You! Actos (pioglitazone) is not yet done making surprises. The British Medical Journal (BMJ) published a study on May 31, 2012 showing an Actos bladder cancer link with number double than hitherto believed: a